- Home
- Applications
- USA
- clinical stage
Show results for
Refine by
Clinical Stage Product Applications In Usa
1 applications found
Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. ...
ByFinch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA)
